Table of Contents  

Upcoming therapeutic options for progressive multiple sclerosis

Fritz Leutmezer
Published in : HAMDAN MEDICAL JOURNAL ; Vol 10, No 4 (2017)
DOI : 10.7707/hmj.809


Although a wide range of therapeutic options are available for relapsing–remitting multiple sclerosis (MS), the therapeutic landscape for progressive forms of the disease is highly unsatisfactory. Therefore, the identification of effective therapies for progressive MS (PMS) is a highly relevant challenge for the global MS medical community. To achieve this, a better understanding of the mechanisms involved in PMS is required through novel clinical trial designs, new drug repurposing strategies and new methods of collaboration in identifying effective therapies. In this review, we discuss the first compounds already available for PMS as well as other therapies currently undergoing phase II and III clinical trials.

View article in  :   PDF     HTML    

View all comments  |  Add comment 

Home  Editorial Board  Search  Current Issue  Archive Issues  Announcements  Aims & Scope  About the Journal  How to Submit  Contact Us
Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2012 - 2013 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA